• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries.

作者信息

Oddens B J, Boulet M J, Lehert P, Visser A P

机构信息

International Health Foundation, Geneva, Switzerland.

出版信息

Maturitas. 1992 Dec;15(3):171-81. doi: 10.1016/0378-5122(92)90200-n.

DOI:10.1016/0378-5122(92)90200-n
PMID:1465031
Abstract

In order to compare the use of hormone replacement therapy (HRT), non-hormonal treatment for the menopause, and tranquillizers, samples of about 300 women aged over 40 were interviewed in France, the United Kingdom, the former West Germany and Italy. The proportion of women in the samples using HRT varied from 3% in Italy to 25% in Germany. The figures for non-hormonal treatment ranged from 2-13%, and for tranquillizers from 5-28%. The use of both HRT and non-hormonal treatment was found to be related to the perimenopause and the corresponding age groups and that of HRT to higher educational level. Tranquillizer use was related to the postmenopause and lower educational level. After controlling for potential confounding effects of menopausal status, educational level, gainful employment and civil status, it emerged that HRT use rates varied significantly between the countries surveyed. It is concluded that cultural differences exist between these countries as to the prescription and acceptance of HRT.

摘要

相似文献

1
Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries.
Maturitas. 1992 Dec;15(3):171-81. doi: 10.1016/0378-5122(92)90200-n.
2
A study on the use of medication for climacteric complaints in western Europe--II.
Maturitas. 1994 May;19(1):1-12. doi: 10.1016/0378-5122(94)90036-1.
3
Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.激素替代疗法使用的重要因素:一项基于瑞典女性人群的研究。隆德地区女性健康(WHILA)研究。
Menopause. 2000 Jul-Aug;7(4):273-81.
4
Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.激素替代疗法首次处方的决定因素。一项针对1689名45至60岁女性的随访研究。
Maturitas. 1994 Dec;20(2-3):81-9. doi: 10.1016/0378-5122(94)90003-5.
5
Correlates of hormone replacement therapy use in Italian women, 1992-1996.1992 - 1996年意大利女性激素替代疗法使用情况的相关因素
Maturitas. 1999 Oct 24;33(2):107-15. doi: 10.1016/s0378-5122(99)00055-9.
6
What women want from hormone replacement therapy: results of an international survey.
Eur J Obstet Gynecol Reprod Biol. 1996 Apr;64 Suppl:S21-4. doi: 10.1016/0301-2115(95)02352-6.
7
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.更年期医学:欧洲更年期与男性更年期协会(EMAS)2004/2005年关于围绝经期和绝经后激素替代疗法的立场声明。
Maturitas. 2005 May 16;51(1):8-14. doi: 10.1016/j.maturitas.2005.02.019.
8
Spanish post-menopausal women's viewpoints on hormone therapy.西班牙绝经后女性对激素疗法的看法。
Maturitas. 2007 Apr 20;56(4):420-8. doi: 10.1016/j.maturitas.2006.11.006. Epub 2006 Dec 14.
9
The view of women aged 45-65 and their partners on aspects of the climacteric phase of life.
Eur J Obstet Gynecol Reprod Biol. 1994 Nov;57(2):95-101. doi: 10.1016/0028-2243(94)90050-7.
10
Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.丹麦45至65岁女性的激素替代疗法:患病率、决定因素及依从性。
Obstet Gynecol. 1997 Aug;90(2):269-77. doi: 10.1016/S0029-7844(97)00264-0.

引用本文的文献

1
Investigation of the role of herbal medicine, acupressure, and acupuncture in the menopausal symptoms: An evidence-based systematic review study.草药、指压按摩和针灸在更年期症状中的作用研究:一项基于证据的系统评价研究。
J Family Med Prim Care. 2020 Jun 30;9(6):2638-2649. doi: 10.4103/jfmpc.jfmpc_1094_19. eCollection 2020 Jun.
2
Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for Menopause Rating Scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women.症状频率、严重症状的决定因素、绝经评定量表(MRS)作为一种筛查工具的有效性和截断值:尼泊尔中年女性的横断面研究。
BMC Womens Health. 2011 Jun 14;11:30. doi: 10.1186/1472-6874-11-30.
3
Assessment of menopausal symptoms using modified Menopause Rating Scale (MRS) among middle age women in Kuching, Sarawak, Malaysia.
在马来西亚砂拉越古晋的中年女性中,使用改良更年期评定量表(MRS)评估更年期症状。
Asia Pac Fam Med. 2010 Feb 22;9(1):5. doi: 10.1186/1447-056X-9-5.
4
Hormone replacement therapy: knowledge, attitudes, and well-being among middle-aged Australian women.激素替代疗法:澳大利亚中年女性的知识、态度与幸福感
Int J Behav Med. 1996;3(3):202-20. doi: 10.1207/s15327558ijbm0303_2.
5
Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.1990 - 1995年在一家管理式医疗组织中绝经后激素替代疗法的使用 prevalence 和持续时间
J Gen Intern Med. 2000 Aug;15(8):542-50. doi: 10.1046/j.1525-1497.2000.03499.x.
6
[Factors influencing the adoption of hormone replacement therapy].[影响激素替代疗法采用的因素]
Can Fam Physician. 1998 Jun;44:1280-6.
7
Gonadal hormone substitutes: effects on the cardiovascular system.性腺激素替代物:对心血管系统的影响。
Osteoporos Int. 1997;7 Suppl 1:S43-51. doi: 10.1007/BF01674813.
8
Utilisation of hormone replacement therapy by women doctors.女医生对激素替代疗法的使用情况。
BMJ. 1995 Nov 25;311(7017):1399-401. doi: 10.1136/bmj.311.7017.1399.